Chief Healthcare Executive September 13, 2024
The U.S. healthcare industry is, in a word, enormous. Health expenditure as a share of GDP hovers around 17%, representing the third largest portion of the economy. For that reason, the industry is, in another word, consequential. How it fares has a meaningful impact on the economy, market, and labor force writ large, which is why examining the industry’s investment trends is a critical bellwether for economic health.
Over the last few years, the results of that examination have been less than stellar. Healthcare deal volume was heavily impacted by the pandemic and compounded by interest rates, labor shortages, regulatory scrutiny, and lack of buyer confidence.
The prognosis for the rest of 2024 is, however, cautiously optimistic – particularly for...